Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer
The present application relates to activable inorganic nanoparticles which can be used in the health sector, in particular in human health, to disturb, alter or destroy target cancerous cells, tissues or organs. It more particularly relates to nanoparticles which can generate a surprisingly efficient therapeutic effect, when concentrated inside the tumor and exposed to ionizing radiations. The invention also relates to pharmaceutical compositions comprising a population of nanoparticles as defined previously, as well as to their uses.
1. A method for treating solid tumor cancer comprising administering to a human subject suffering from a solid tumor cancer by intra-tumoral injection a composition comprising a suspension of inorganic nanoparticles, determining the volume of the composition comprising the inorganic nanoparticles within the tumor volume by radiography or computed tomography, and exposing the tumor of the human subject to ionizing radiation, wherein the inorganic nanoparticles provide more than 7×10 22 electrons to the tumor, the inorganic material constituting the nanoparticles having a theoretical (bulk) density of at least 7 and an effective atomic number (Z eff ) of at least 25, and the volume of the composition (Vc) occupies between 2% and 55% of the tumor volume.
2. The method according to claim 1 , wherein said ionizing radiation is selected from X-rays, ion beams, electron beams, gamma-rays, or a radioactive isotope.
3. The method according to claim 1 , wherein said composition has a volume that is between 2% and 45% of the tumor volume.
4. The method according to claim 1 , wherein the inorganic material constituting the nanoparticles is selected from an oxide, a metal, a sulfide and any mixture thereof.
5. The method according to claim 4 , wherein the inorganic material constituting the nanoparticles is a metal oxide and is selected from Cerium (IV) oxide (CeO 2 ), Neodymium (III) oxide (Nd 2 O 3 ), Samarium (III) oxide (Sm 2 O 3 ), Europium (III) oxide (EU 2 O 3 ), Gadolinium (III) oxide (Gd 2 O 3 ), Terbium (III) oxide (Tb 2 O 3 ), Dysprosium (III) oxide (Dy 2 O 3 ), Holmium oxide (Ho 2 O 3 ), Erbium oxide (Er 2 O 3 ), Thulium (III) oxide (Tm 2 O 3 ), Ytterbium oxide (Yb 2 O 3 ), Lutetium oxide (Lu 2 O 3 ), Hafnium (IV) oxide (HfO 2 ), Tantalum (V) oxide (Ta 2 O 5 ), Rhenium (IV) oxide (ReO 2 ), and Bismuth (III) oxide (Bi 2 O 3 ) and any mixture thereof.
6. The method according to claim 4 , the inorganic material constituting the nanoparticles is a metal selected from gold (Au), silver (Ag), platinum (Pt), palladium (Pd), tin (Sn), tantalum (Ta), ytterbium (Yb), zirconium (Zr), hafnium (HI), terbium (Tb), thulium (Tm), cerium (Ce), dysprosium (Dy), erbium (Er), europium (Eu), holmium (Ho), iron (Fe), lanthanum (La), neodymium (Nd), praseodymium (Pr), lutetium (Lu) and any mixture thereof.
7. The method according to claim 4 , wherein the inorganic material is selected from a hafnium oxide, zirconium oxide, rhenium oxide, europium oxide and any mixture thereof.
8. The method according to claim 1 , wherein the inorganic nanoparticles comprise a mixture of an inorganic oxide and of a metal.
9. The method according to claim 1 , wherein the largest dimension of a nanoparticle is between about 5 nm and about 250 nm.
10. The method according to claim 1 , said method comprising determining the electron density of the volume of the composition comprising the inorganic nanoparticles (Vc) and administering to the human subject a volume of the inorganic nanoparticles that occupies between 2.5% and 50% of the tumor volume.
11. The method according to claim 10 , wherein the inorganic nanoparticles comprise an inorganic material that has an effective atomic number (Z eff ) of at least 40.
12. The method according to claim 1 , wherein the method comprises a step of calculating the quantity of electrons provided by the inorganic nanoparticles to the tumor using the following formula:
Quantity of electrons= V NP (cm 3 )×ρ e − material ,
with ρ e − material =d material ×e − material and V NP (cm 3 )=X mean × Vc (cm 3 )/d material (g/cm 3 )/1000 (cm 3 ), wherein d material is the theoretical (bulk) density of material constituting the inorganic nanoparticles, e − material is the number of electrons per gram of the material constituting the inorganic nanoparticles, Vc represents volume composition and corresponds to the volume of the suspension of inorganic nanoparticles which is administered to the human subject, and X mean corresponds to the concentration of the suspension of inorganic nanoparticles which is injected into the tumor.